PET imaging of inflammation predicts recovery, guides therapy after heart attack

A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...
Medscape

Understanding the Real Impact of Time Changes

It’s that time of year again — one of the two biannual time changes, this return to standard time. While Americans dislike ...

Gastroesophageal reflux disease linked to increased risk for incident acute myocardial infarction

Patients with preexisting gastroesophageal reflux disease (GERD) have an increased risk for incident acute myocardial ...
The Cardiology Advisor

AHA Issues Statement on Post-Myocardial Infarction Psychological Distress

The American Heart Association has published a scientific statement regarding post-myocardial infarction psychological distress.
Open Heart

Impact of the COVID-19 pandemic on incidence of myocardial infarction, heart failure and stroke, by mental disorder diagnosis, in England, 2019–2023: a cohort study

Background We aimed to estimate mental disorder disparities in cardiovascular disease (CVD) incidence and determine whether ...
MassDevice

Johnson & Johnson MedTech reports positive Impella findings, updated guidelines

Johnson & Johnson MedTech today announced new data confirming the benefits of its Abiomed business' Impella CP system.
Becker's ASC

GLP-1s and cardiac health: 5 study notes

Semaglutide can reduce cardiac event risk regardless of a patient’s starting body fat or weight loss during treatment, ...
The Globe and Mail

Myocardial Infarction Pipeline Drugs Report 2025: Evaluating Cutting-Edge Therapies, Clinical Trial Milestones, Key Companies, and Emerging SMA Treatment Options

DelveInsight’s, “Myocardial Infarction Pipeline Insight, 2025” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction pipeline landscape. It covers ...